Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Lobe Sciences Ltd.
Lobe Sciences Appoints Tracy L. Goeken, M.D., as Chief Medical Officer
October 20, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Appoints Annette Grimaldi, Former Head of Life Sciences Investment Banking at BMO Capital Markets, to Board of Directors
October 14, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Announces Proposed Capital Markets Initiatives to Support Planned Growth
October 08, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit
September 14, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Ltd. Announces Closing of Upsize to Non-Brokered Private Placement
August 31, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
August 28, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Expands Leadership Team with New CFO Appointment
August 28, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement
August 20, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Reports Third Quarter 2026 Financial Results
August 18, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Ltd. Announces Non-Brokered Private Placement
August 12, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Announces Results of Annual General and Special Meeting of Shareholders
August 05, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Files Management Information Circular for Annual General and Special Meeting on July 30, 2026
July 07, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Conjugated Psilocin™
November 18, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Announces Update
June 04, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise
June 03, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors
May 31, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Former Merck Director and Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, to Join Lobe Sciences Board of Directors
May 30, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders
May 21, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Provides Company Review of 2023
January 08, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Provides Update on L-130 Clinical Program
December 07, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Provides Update on L-130 Oral Psilocin Compound
December 05, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia™ & Company
September 14, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Initiates Phase 1 Clinical Trial of L-130
June 27, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Appoints Baxter Phillips III, MBA as Chief Operating Officer
June 07, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia™
May 17, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Tickers
CSE:LOBE
LOBEF
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
